Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- PMID: 26462617
- PMCID: PMC4604472
- DOI: 10.1038/srep15179
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Abstract
The prognostic value of FoxP3(+) regulatory T cells (Tregs) in cancer remains controversial. We did a meta-analysis to assess the prognostic effect of FoxP3(+) Treg across different types of cancer and to investigate factors associated with variations in this effect. PubMed, Embase, Cochrane CENTRAL, and Scopus were searched to identify eligible studies. In total, we analyzed 76 articles encompassing 17 types of cancer, and including 15,512 cancer cases. The overall pooled analysis including all types of cancer suggested FoxP3(+)Tregs had a significant negative effect on overall survival (OS) (OR 1.46, P < 0.001), but the prognostic effect varied greatly according to tumor site. High FoxP3(+) Tregs infiltration was significantly associated with shorter OS in the majority of solid tumors studied, including cervical, renal, melanomas, and breast cancers, et al; whereas, FoxP3(+) Tregs were associated with improved survival in colorectal, head and neck, and oesophageal cancers. The stratified analysis suggested the molecular subtype and tumor stage significantly influenced the prognostic value of FoxP3(+) Tregs in certain types of cancer. In conclusion, our meta-analysis suggests that the prognostic role of FoxP3(+) Tregs was highly influenced by tumor site, and was also correlated with the molecular subtype and tumor stage.
Figures
Similar articles
-
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis.BMC Cancer. 2016 Aug 26;16(1):687. doi: 10.1186/s12885-016-2732-0. BMC Cancer. 2016. PMID: 27566250 Free PMC article.
-
The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis.Clin Transl Oncol. 2023 Jun;25(6):1830-1843. doi: 10.1007/s12094-023-03080-1. Epub 2023 Jan 24. Clin Transl Oncol. 2023. PMID: 36692642
-
The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.J Cancer Res Clin Oncol. 2013 Nov;139(11):1845-52. doi: 10.1007/s00432-013-1500-7. Epub 2013 Sep 5. J Cancer Res Clin Oncol. 2013. PMID: 24005418 Free PMC article.
-
Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer.J Cancer Res Clin Oncol. 2010 Oct;136(10):1585-95. doi: 10.1007/s00432-010-0816-9. Epub 2010 Mar 11. J Cancer Res Clin Oncol. 2010. PMID: 20221835 Free PMC article.
-
Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.Oncotarget. 2016 Jun 14;7(24):36065-36073. doi: 10.18632/oncotarget.9130. Oncotarget. 2016. PMID: 27153545 Free PMC article.
Cited by
-
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma.Front Oncol. 2021 Feb 25;11:625207. doi: 10.3389/fonc.2021.625207. eCollection 2021. Front Oncol. 2021. PMID: 33718189 Free PMC article.
-
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial.J Immunother Cancer. 2024 Oct 4;12(10):e009662. doi: 10.1136/jitc-2024-009662. J Immunother Cancer. 2024. PMID: 39366752 Free PMC article. Clinical Trial.
-
The Density of CD8+ Tumor-infiltrating Lymphocytes Correlated With Akt Activation and Ki-67 Index in Canine Soft Tissue Sarcoma.In Vivo. 2024 Jul-Aug;38(4):1698-1711. doi: 10.21873/invivo.13620. In Vivo. 2024. PMID: 38936907 Free PMC article.
-
The tumor-stroma ratio in giant cell tumor of bone: associations with the immune microenvironment and responsiveness to denosumab treatment.J Orthop Surg Res. 2024 Jul 15;19(1):405. doi: 10.1186/s13018-024-04885-8. J Orthop Surg Res. 2024. PMID: 39010095 Free PMC article.
-
M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.Front Immunol. 2022 Sep 13;13:994019. doi: 10.3389/fimmu.2022.994019. eCollection 2022. Front Immunol. 2022. PMID: 36177006 Free PMC article.
References
-
- Galon J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313, 1960–1964 (2006). - PubMed
-
- deLeeuw R. J., Kost S. E., Kakal J. A. & Nelson B. H. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18, 3022–3029 (2012). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources